SecBot SecBot
F-1/A ·Filed Apr 23, 2026

OPTHF

Optimi Health Corp.
NEUTRAL
Impact 5/10
Horizonweeks Processed6mo ago SEC0001193125-26-173667
Foreign IPO amendment
Actionable Insight • Neutral

Monitor the next 10-Q filing for guidance on how the IPO proceeds will be allocated, particularly regarding scaling production and market expansion plans.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled — T+20d
OPTHF ▼ -11.04% at T+20d
NEUTRAL call -11.04% · α vs SPY -15.07% · entry $0.2644 → $0.2352
Next anchor: T+60d due 3mo ago
Entry = T+0 close
Apr 23, 2026
via day close
T+1d
-4.33%
call -4.33% · α -4.49%
$0.2530
settled 6mo ago
T+5d
+2.18%
call +2.18% · α +1.27%
$0.2702
settled 6mo ago
T+20d
-11.04%
call -11.04% · α -15.07%
$0.2352
settled 5mo ago
T+60d
Pending
due 3mo ago

Executive Summary

Optimi Health Corp., a Canadian psychedelic pharmaceutical company, is conducting its U.S. IPO by registering 2.5 million common shares. The expected offering price is between $6.00 and $8.00 per share, with a total maximum aggregate offering price of $38.985 million. This filing is an amendment to update the filing fee table, indicating the IPO process is advancing toward effectiveness.

Key Financial Metrics

Price Range
$6.00-$8.00 per share

Key Facts

  • Optimi Health Corp. is a Canadian psychedelic pharmaceutical company
  • The company is conducting its U.S. IPO by registering 2.5 million common shares
  • The expected offering price is between $6.00 and $8.00 per share
  • The total maximum aggregate offering price is $38.985 million
  • This filing is an amendment to update the filing fee table
  • The IPO process is advancing toward effectiveness

Financial Impact

The offering could raise up to $38.985 million at the maximum price point

revenuedilutionproceeds

Risk Factors

  • The company has a history of operating losses
  • There is substantial doubt about the company's ability to continue as a going concern

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 2 SEC documents filed with EDGAR.

DocumentAccession Number
F-1/A Filing (Primary)0001193125-26-173667
Document: d43258dex11.htm0001193125-26-173667
4 reports for OPTHF
Performance horizon
Filters
Rows
Reports for OPTHF — sortable, filterable
TypeNow
May 26, 2026
21w ago
6-K
NEUTRAL ★ 4/10
—awaiting T+20——
May 19, 2026
22w ago
F-1/A
NEUTRAL ★ 5/10
$0.2352awaiting T+20——
Apr 23, 2026
26w ago
F-1/A
NEUTRAL ★ 5/10
$0.2644 $0.2352▼ −11.04%▼ −15.07%—
Apr 21, 2026
26w ago
F-1/A
NEUTRAL ★ 5/10
$0.2680 $0.2352▼ −12.24%▼ −15.40%—
Showing 4 of 4

US Market Status

Market Closed — Opens Tue (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 23, 2026